Evosep ApS

The main activities of the Group include development and marketing of laboratory equipment, including chromatography instruments and associated consumables and other related activities.

The current composition of the Group includes Evosep ApS, Evosep Biolabs ApS, Evosep Inc., and Evosep Biolabs Inc.

Financial review

In the Annual Report of 2024, we stated that we expected a pre-tax result before tax in the range of mDKK -5 to -1, due to substantial investments into market development and future scalability.…

As we enter 2026 the Group’s main activities will remain unchanged and we will continue to pursue market expansion. We expect profit before tax to land in the mDKK 8–15 range, reflecting the returns on investments made in recent years while also accounting for continued substantial investment in market development and scalability.

Subsequent eventsNo events materially affecting the Group’s financial position have occurred subsequent to the financial year-end.

Deferred tax asset is composed of tax losses carried forward as well as temporary differences between the tax base of assets and liabilities and their carrying amount, primarily property, plant and equipment and prepayments.

When recognising and measuring the deferred tax asset, special emphasis is placed on the assumption that tax losses are expected to be used over the next 3-5 years by offsetting expected profits as a result of the increased operating activity and earnings in the group and parent company. There is, by nature, an uncertainty attached to the level of the group and parent company’s future earnings.

Recognition and measurement uncertaintiesThe recognition and measurement of items in the annual report is not associated with any uncertainty.

Deferred tax asset is composed of tax losses carried forward as well as temporary differences between the tax base of assets and liabilities and their carrying amount, primarily property, plant and equipment and prepayments.

When recognising and measuring the deferred tax asset, special emphasis is placed on the assumption that tax losses are expected to be used over the next 3-5 years by offsetting expected profits as a result of the increased operating activity and earnings in the Group and Parent Company. There is, by nature, an uncertainty attached to the level of the Group and Parent Company’s future earnings.

Recourse and non-recourse guarantee commitmentsThe parent company is jointly taxed with its Danish group entities. The entities are jointly and severally liable for Danish income taxes as well as withholding taxes on dividends, interest and royalties payable by the group of jointly taxed entities. Due income taxes and withholding taxes payable by the group of jointly taxed entities totals DKK 0 at 31 December 2025. Any subsequent corrections of income taxes and withholding taxes may increase the tax payable by the entities. The group as such is not liable to any third parties.

Contingent liabilities related to group enterprisesFinancial supportEvosep ApS has issued a letter of support to provide unlimited financial support to the parent company's subsidiary Evosep Inc. until 26 August 2027.